Ocular Therapeutix Inc (OCUL)
6.045
+0.18
(+3.07%)
USD |
NASDAQ |
May 03, 09:31
Ocular Therapeutix 1 Year Total Returns (Daily): -1.76% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 02, 2024 | -1.76% |
May 01, 2024 | -18.77% |
April 30, 2024 | -23.55% |
April 29, 2024 | -22.58% |
April 26, 2024 | -21.05% |
April 25, 2024 | -28.81% |
April 24, 2024 | -25.08% |
April 23, 2024 | -22.24% |
April 22, 2024 | -21.07% |
April 19, 2024 | -10.31% |
April 18, 2024 | 2.27% |
April 17, 2024 | 30.69% |
April 16, 2024 | 48.10% |
April 15, 2024 | 48.29% |
April 12, 2024 | 57.28% |
April 11, 2024 | 58.32% |
April 10, 2024 | 53.59% |
April 09, 2024 | 58.33% |
April 08, 2024 | 54.84% |
April 05, 2024 | 71.54% |
April 04, 2024 | 69.06% |
April 03, 2024 | 61.26% |
April 02, 2024 | 60.91% |
April 01, 2024 | 64.90% |
March 28, 2024 | 79.49% |
Date | Value |
---|---|
March 27, 2024 | 81.13% |
March 26, 2024 | 86.99% |
March 25, 2024 | 91.26% |
March 22, 2024 | 95.67% |
March 21, 2024 | 97.86% |
March 20, 2024 | 103.7% |
March 19, 2024 | 95.56% |
March 18, 2024 | 90.32% |
March 15, 2024 | 85.49% |
March 14, 2024 | 81.57% |
March 13, 2024 | 91.04% |
March 12, 2024 | 90.76% |
March 11, 2024 | 99.79% |
March 08, 2024 | 77.26% |
March 07, 2024 | 76.51% |
March 06, 2024 | 94.09% |
March 05, 2024 | 84.94% |
March 04, 2024 | 84.09% |
March 01, 2024 | 77.10% |
February 29, 2024 | 66.56% |
February 28, 2024 | 64.74% |
February 27, 2024 | 66.11% |
February 26, 2024 | 67.23% |
February 23, 2024 | 63.52% |
February 22, 2024 | 60.07% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-81.37%
Minimum
Apr 29 2022
465.3%
Maximum
Dec 15 2020
33.44%
Average
2.56%
Median
Jan 24 2024
1 Year Total Returns (Daily) Benchmarks
Amgen Inc | 21.94% |
Assertio Holdings Inc | -82.56% |
CytomX Therapeutics Inc | 172.1% |
EyePoint Pharmaceuticals Inc | 207.1% |
Regeneron Pharmaceuticals Inc | 17.43% |